Compare PNRG & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNRG | CGC |
|---|---|---|
| Founded | 1973 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Pharmaceuticals and Biotechnology |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 344.8M | 389.2M |
| IPO Year | 1995 | 2023 |
| Metric | PNRG | CGC |
|---|---|---|
| Price | $215.91 | $0.93 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $160.00 | N/A |
| AVG Volume (30 Days) | 74.8K | ★ 3.1M |
| Earning Date | 04-16-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.17 |
| EPS | ★ 4.57 | N/A |
| Revenue | ★ $189,052,000.00 | $12,759,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | $18.18 | $15.68 |
| P/E Ratio | $46.70 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $126.40 | $0.84 |
| 52 Week High | $278.90 | $2.38 |
| Indicator | PNRG | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 58.83 | 36.85 |
| Support Level | $202.23 | $0.91 |
| Resistance Level | $225.59 | $1.15 |
| Average True Range (ATR) | 7.78 | 0.03 |
| MACD | -1.06 | -0.01 |
| Stochastic Oscillator | 52.26 | 3.54 |
PrimeEnergy Resources Corp is an independent oil and natural gas company that is engaged in acquiring, developing, and producing oil and natural gas. It owns producing and non-producing properties located in Texas and Oklahoma. The company's business activities include development and exploratory drilling and providing well servicing support operations for many of the onshore oil and gas wells through its subsidiaries. It is also active in the acquisition of producing oil and gas properties through joint ventures with industry partners.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.